OncoDNA Signs Agreement with its Middle-East Distributor CryoGene for the MOCS (Multi-centric OncoDNA Combined Study) Research

This project is the first prospective regional molecular profiling program that combines liquid and solid analyses aspiring to improve the lives of patients with... Read More
May 17, 2017

Rady Children’s Institute for Genomic Medicine and Alexion Pharmaceuticals Partner to Speed the Diagnosis of Rare Genetic Disorders in Newborns

The Rady Children’s Institute for Genomic Medicine (RCIGM) and Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) have announced a strategic partnership to accelerate the diagnosis of... Read More
May 17, 2017

Phase Genomics Announces the Commercial Availability of ProxiMeta™ Hi-C

Seattle-based Phase Genomics announced today the general availability of its new ProxiMeta™ Hi-C metagenomic deconvolution service. ProxiMeta enables researchers to obtain complete, distinct genomes... Read More
May 17, 2017

Penn Medicine Researchers Identify Biomarkers That May Predict Cognitive Impairment in New Parkinson’s Disease Patients

New biomarkers identified by a research team in the Perelman School of Medicine at the University of Pennsylvania could help predict which Parkinson’s disease... Read More
May 17, 2017

Agilent Technologies Announces Expanded Use for PD-L1 IHC 28-8 pharmDx Diagnostic in Europe

Agilent Technologies Inc. (NYSE: A) today announced the expanded use of Agilent´s Dako PD-L1 IHC 28-8 pharmDx test for squamous cell carcinoma of the... Read More
April 29, 2017

Tempus Announces BRCA Focused Initiative in Partnership with Penn’s Basser Center for BRCA

Tempus, a technology company focused on helping doctors personalize cancer treatment by collecting, sorting and analyzing clinical and molecular data, has announced a new... Read More
April 29, 2017

ChromaCode Raises $12 Million in Series B Funding for Commercial Launch and Appoints Alex Dickinson as Executive Chair

ChromaCode, Inc., a molecular diagnostics company, announced it has raised $12 million in Series B funding. This latest round is led by New Enterprise... Read More
April 29, 2017

WorldQuant Initiative for Quantitative Prediction established at Weill Cornell Medicine

Weill Cornell Medicine has announced a gift made by WorldQuant, LLC (“WorldQuant”) and Igor Tulchinsky that will further realize the promise of precision medicine.... Read More
April 24, 2017

Diaceutics announces 30 jobs on back of 60% revenue growth

Diaceutics, the Irish data insights and solutions company enabling better patient testing globally, has announced 30 new jobs as it continues to lead the... Read More
April 24, 2017

Top three global diagnostics company takes exclusive rights to several of Avacta’s Affimer reagents

Avacta Group plc (AIM: AVCT) (Avacta), the developer of Affimer® biotherapeutics and research reagents, is pleased to report that an evaluation of the Affimer... Read More
April 21, 2017

Verily Launches Landmark Study With Duke and Stanford as First Initiative of Project Baseline

Verily Life Sciences LLC, an Alphabet company, in partnership with Duke University School of Medicine and Stanford Medicine, announced the initiation of the Project... Read More
April 21, 2017

Congenica and Edico Genome Partner to Speed Analysis from ‘DNA to Diagnosis’ for Inherited Diseases

CAMBRIDGE, UK and SAN DIEGO – April 20, 2017 – Congenica and Edico Genome announced the companies have partnered to offer their complementary platform... Read More
April 21, 2017

JAX’S Maine Cancer Genomics Initiative Achieves Key Milestones In Bringing Precision Cancer Care To Maine

The Jackson Laboratory (JAX), an independent, nonprofit biomedical research institution, announced that its Maine Cancer Genomics Initiative (MCGI) has accomplished key milestones toward its... Read More
March 2, 2017

Dr. Stephen Kingsmore – A Vision for Transforming Medicine with Rapid Genome Sequencing (Part 1)

Dr. Stephen Kingsmore, MD, DSc, is the President and CEO of the Rady Pediatric Genomics and Systems Medicine Institute. Dr. Kingsmore spoke at the... Read More
March 1, 2017

Freenome Announces $65 Million in Series A Funding, Led by Andreessen Horowitz

Freenome, the health technology company reinventing disease management through systematized early detection and intervention, announced today that it has raised $65 million USD in... Read More
March 1, 2017

Illumina Announces the iHope Network, an Expansion of Its iHope Philanthropic Clinical Whole Genome Sequencing Program

Illumina, Inc. has announced the launch of the iHope Network, a consortium of member institutions who have committed to providing clinical whole genome sequencing... Read More